Chevy Chase Trust Holdings LLC Raises Stock Holdings in The Cooper Companies, Inc. $COO

Chevy Chase Trust Holdings LLC boosted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 0.8% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 105,725 shares of the medical device company’s stock after acquiring an additional 857 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in Cooper Companies were worth $7,523,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. raised its holdings in Cooper Companies by 15.1% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company’s stock valued at $2,194,000 after buying an additional 3,440 shares during the period. DAVENPORT & Co LLC raised its holdings in Cooper Companies by 13.4% in the 1st quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company’s stock valued at $366,000 after buying an additional 513 shares during the period. Cerity Partners LLC increased its stake in Cooper Companies by 6.6% during the first quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company’s stock worth $1,443,000 after purchasing an additional 1,054 shares during the period. State of Alaska Department of Revenue increased its stake in Cooper Companies by 3.0% during the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company’s stock worth $1,972,000 after purchasing an additional 680 shares during the period. Finally, United Services Automobile Association purchased a new stake in Cooper Companies during the first quarter worth about $414,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have issued reports on COO. Stifel Nicolaus cut their price target on shares of Cooper Companies from $90.00 to $85.00 and set a “buy” rating on the stock in a research note on Thursday, August 28th. Wall Street Zen lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. Robert W. Baird cut their price target on shares of Cooper Companies from $97.00 to $85.00 and set an “outperform” rating on the stock in a research note on Thursday, August 28th. JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a research note on Thursday, August 28th. Finally, Piper Sandler cut their price target on shares of Cooper Companies from $105.00 to $83.00 and set an “overweight” rating on the stock in a research note on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $84.77.

Insider Transactions at Cooper Companies

In other Cooper Companies news, COO Gerard H. Warner III purchased 1,450 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was purchased at an average cost of $69.23 per share, with a total value of $100,383.50. Following the completion of the acquisition, the chief operating officer directly owned 18,319 shares of the company’s stock, valued at $1,268,224.37. This trade represents a 8.60% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Lawrence Erik Kurzius purchased 2,000 shares of the stock in a transaction that occurred on Monday, September 29th. The stock was acquired at an average cost of $68.39 per share, with a total value of $136,780.00. Following the completion of the acquisition, the director directly owned 5,777 shares of the company’s stock, valued at $395,089.03. This represents a 52.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 17,975 shares of company stock valued at $1,216,346 over the last three months. 1.98% of the stock is owned by corporate insiders.

Cooper Companies Stock Performance

Shares of COO opened at $74.99 on Tuesday. The stock has a 50 day moving average price of $69.60 and a 200 day moving average price of $73.19. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $14.91 billion, a price-to-earnings ratio of 36.94, a price-to-earnings-growth ratio of 1.89 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $109.04.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its board has authorized a stock buyback plan on Wednesday, September 17th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.